Metraipolis › archive › dc_c5dcdec5f407
Pharmacokinetic drug-drug interaction between the COVID-19 3CL protease inhibitor GST-HG171 and itraconazole in healthy subjects — Europe PMC PMID:42112804
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42112804
- DOI
- 10.1128/aac.00285-26
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T12:17:53.425Z
- SHA-256 of the archived text
5bad0630e07e34a25c2c16067ff59dfcb1c310432588a9fdc49bc069bae21670- Stable URL of this page
https://metraipolis.com/documento/dc_c5dcdec5f407
How to cite
Pharmacokinetic drug-drug interaction between the COVID-19 3CL protease inhibitor GST-HG171 and itraconazole in healthy subjects — Europe PMC PMID:42112804 — Europe PMC (en), https://europepmc.org/article/MED/42112804 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c5dcdec5f407 (Metraipolis archive dc_c5dcdec5f407, sha256 5bad0630e07e34a25c2c16067ff59dfcb1c310432588a9fdc49bc069bae21670)
BibTeX
@misc{dcc5dcdec5f407,
title = {Pharmacokinetic drug-drug interaction between the COVID-19 3CL protease inhibitor GST-HG171 and itraconazole in healthy subjects — Europe PMC PMID:42112804},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42112804},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c5dcdec5f407; sha256 5bad0630e07e34a25c2c16067ff59dfcb1c310432588a9fdc49bc069bae21670},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42112804. Agents can read the archived copy with the MCP tool read_document.